Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Hallmarks of aging
Research brief

PREDIFALL protocol: multimodal predictors of falls in healthy adults aged 65 and older

The PREDIFALL protocol describes a planned prospective observational cohort of 100 healthy adults aged 65 and older, combining baseline clinical, functional, sensory, imaging and blood-based assessments with weekly smartphone-based fall monitoring over 12 months. [1]

Automatic summary · not editorially reviewed

The key findings

  1. PREDIFALL is planned as a prospective observational cohort study including 100 healthy adults aged 65 years or older. [1]

  2. At baseline, participants will be classified as fallers or non-fallers based on fall history over the previous 12 months. [1]

  3. Falls will be monitored during a 12-month follow-up with a smartphone-based application completed weekly. [1]

The source at a glance

Study type / format
Prospective observational cohort study protocol (abstract).
Population / context
100 healthy older adults aged 65 years or older (planned).
Summary based on
Study abstract
Publication status
Preprint · peer-review status not confirmed
Original publication
August 18, 2026

Planned cohort of 100 healthy adults aged 65 and older

PREDIFALL is described as a prospective observational cohort study that will include 100 healthy older adults aged 65 years or older. At baseline, participants will be classified as fallers or non-fallers based on their fall history over the previous 12 months. The protocol states that falls result from multiple interacting factors and that current fall assessment often relies on isolated measures.

Supporting source [1]

Baseline assessments across clinical, sensory, imaging and blood measures

The planned baseline assessments include questionnaires, physical activity and sleep monitoring, cognitive testing, mobility and gait evaluation, muscle strength testing, posturography, vestibular and auditory assessment, brain and muscle imaging, and blood-based biomarker and multi-omics analyses. Machine learning approaches are planned to integrate these multimodal data and identify profiles associated with retrospective and prospective falls.

Supporting source [1]

Weekly app-based fall monitoring over 12 months

Falls will subsequently be monitored during a 12-month follow-up using a smartphone-based application completed weekly. The protocol states that this follow-up will help evaluate the feasibility of longitudinal fall monitoring in community-dwelling older adults. The authors expect findings to inform future fall prevention strategies; the abstract reports no results yet.

Supporting source [1]

How to interpret this

This is an abstract of a study protocol; no results are reported. The planned design, sample and follow-up are described, but the full text was not reviewed.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
PREDIFALL - Polymodal Evaluation of Predictors of Falls in Healthy Older Adults: A Prospective Study Protocol

Gökçe E, Marcourt C, Kola A, Robcis S, Ciarfaglia RL, Naveau M, Reyngoudt H, Étard N, Humbert X, Nathou C, Étard O, Gauthier A, Quarck G, Freret T, Loggia G, Denise P, Villain C, Langeard A. · europepmc.org · August 18, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    prospective observational cohort study including 100 healthy
  2. Finding 2 ↑

    fall history over the previous 12 months
  3. Finding 3 ↑

    monitored during the 12-month follow-up using a

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…